Clinical trials data
Clock Drawing Task in dementia and Alzheimer's trials: 69 registered studies
Every registered dementia and Alzheimer's disease study on ClinicalTrials.gov that names the Clock Drawing Task in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered dementia and Alzheimer's disease studies name it in an outcome measure
- 69
- Name it in a primary outcome, 41%
- 28 of 69
Tests named in the same studies
- 1
Trail Making Test33 studies, 11 as a primary outcome
- 2
Verbal Fluency26 studies, 12 as a primary outcome
- 3
Picture Naming Test22 studies, 8 as a primary outcome
- 4
Digit Span Test20 studies, 8 as a primary outcome
- 5
Verbal Learning18 studies, 12 as a primary outcome
- 6
Category Fluency17 studies, 8 as a primary outcome
- 7
Complex Figure Copy and Recall11 studies, 7 as a primary outcome
- 8
Stroop Color-Word Test10 studies, 6 as a primary outcome
- 9
Symbol Coding10 studies, 6 as a primary outcome
- 10
Short Story Recall9 studies, 5 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 2 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 0 |
| 2009 | 2 | 1 |
| 2010 | 2 | 0 |
| 2011 | 0 | 0 |
| 2012 | 2 | 0 |
| 2013 | 4 | 2 |
| 2014 | 1 | 0 |
| 2015 | 3 | 2 |
| 2016 | 2 | 1 |
| 2017 | 4 | 2 |
| 2018 | 4 | 2 |
| 2019 | 6 | 3 |
| 2020 | 2 | 0 |
| 2021 | 7 | 4 |
| 2022 | 6 | 2 |
| 2023 | 3 | 0 |
| 2024 | 6 | 4 |
| 2025 | 8 | 4 |
| 2026 | 2 | 1 |
Phases and study sizes
By phase
- Phase 1/21 studies, 0 as a primary outcome
- Phase 28 studies, 1 as a primary outcome
- Phase 35 studies, 1 as a primary outcome
- Phase 42 studies, 0 as a primary outcome
- Not applicable33 studies, 14 as a primary outcome
- Observational20 studies, 12 as a primary outcome
Participants per study
- Not applicable60 median, 30 to 122
- Observational155 median, 88 to 392
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 32 | 60 | 30 to 122 |
| Observational | 20 | 155 | 88 to 392 |
When dementia and Alzheimer's trials measure it
Latest time point of each outcome
- Within a day4 outcomes, 2 as a primary outcome
- Up to 4 weeks9 outcomes, 4 as a primary outcome
- 1 to 3 months9 outcomes, 5 as a primary outcome
- 3 to 6 months17 outcomes, 5 as a primary outcome
- 6 to 12 months13 outcomes, 4 as a primary outcome
- 1 to 2 years8 outcomes, 3 as a primary outcome
- Over 2 years5 outcomes, 3 as a primary outcome
- No duration given4 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
65 of the 69 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting8 studies, 5 as a primary outcome
- Not yet recruiting3 studies, 0 as a primary outcome
- Active, not recruiting3 studies, 2 as a primary outcome
- Completed34 studies, 12 as a primary outcome
- Stopped early5 studies, 3 as a primary outcome
- Status unknown16 studies, 6 as a primary outcome
What they test
- Behavioral13 studies, 5 as a primary outcome
- Drug17 studies, 5 as a primary outcome
- Device11 studies, 6 as a primary outcome
- Dietary supplement2 studies, 0 as a primary outcome
- Procedure4 studies, 1 as a primary outcome
- Diagnostic test3 studies, 1 as a primary outcome
- Biological2 studies, 1 as a primary outcome
- Radiation1 studies, 1 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Genetic1 studies, 1 as a primary outcome
- Other12 studies, 4 as a primary outcome
- None given12 studies, 8 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States15 studies, 6 as a primary outcome
- China14 studies, 3 as a primary outcome
- Italy9 studies, 7 as a primary outcome
- France6 studies, 0 as a primary outcome
- Norway6 studies, 1 as a primary outcome
- Türkiye6 studies, 1 as a primary outcome
- Australia4 studies, 1 as a primary outcome
- Canada3 studies, 0 as a primary outcome
- Greece3 studies, 2 as a primary outcome
- Spain3 studies, 1 as a primary outcome
- Austria2 studies, 0 as a primary outcome
- Germany2 studies, 0 as a primary outcome
43 countries in all. A study with sites in several counts in each; 2 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed dementia and Alzheimer's disease studies that name the Clock Drawing Task: 22 of 34, 65%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed dementia and Alzheimer's disease studies that name the Clock Drawing Task | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 3, 9% | 776, 10% |
| Results on ClinicalTrials.gov only | 7, 21% | 1,139, 14% |
| A results paper only | 12, 35% | 1,711, 22% |
| Neither | 12, 35% | 4,327, 54% |
The 69 studies
69 studies match. 28 name the Clock Drawing Task in a primary outcome. Median size 95 participants. Median time to the primary outcome: 5 months.
Loading 69 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 2 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 0 |
| 2009 | 2 | 1 |
| 2010 | 2 | 0 |
| 2011 | 0 | 0 |
| 2012 | 2 | 0 |
| 2013 | 4 | 2 |
| 2014 | 1 | 0 |
| 2015 | 3 | 2 |
| 2016 | 2 | 1 |
| 2017 | 4 | 2 |
| 2018 | 4 | 2 |
| 2019 | 6 | 3 |
| 2020 | 2 | 0 |
| 2021 | 7 | 4 |
| 2022 | 6 | 2 |
| 2023 | 3 | 0 |
| 2024 | 6 | 4 |
| 2025 | 8 | 4 |
| 2026 | 2 | 1 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 12, other 57. Interventional 49, observational 20.
As a primary outcomeSecondary or other outcomeThe Clock Drawing Task
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07664865 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants250 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07651085 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Parkinson's disease, Sleep and sleep disorders | Participants65 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07467460 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's, Parkinson's disease, Obesity and diabetes | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07399418 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07385937 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07375771 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07279103 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants24 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07089303 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants750 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06946511 | Start2025 | PhasePhase 1/2 | ConditionsDementia and Alzheimer's | Participants50 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06803784 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Parkinson's disease | Participants110 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06765434 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants54 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06595511 | Start2022 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants30 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06484244 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants10 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06452147 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Delirium, surgery and intensive care | Participants1,860 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06380725 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06094452 | Start2020 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants84 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06083350 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants144 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06080659 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Parkinson's disease | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06078332 | Start2021 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants114 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05887674 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants180 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05647473 | Start2024 | PhasePhase 2 | ConditionsDementia and Alzheimer's, Cardiovascular disease | Participants66 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05623124 | Start2021 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants400 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05578443 | Start2024 | PhasePhase 2 | ConditionsDementia and Alzheimer's | Participants66 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05575271 | Start2022 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants6 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT05558839 | Start2021 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants41 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many dementia and Alzheimer's trials use the Clock Drawing Task?
69 registered dementia and Alzheimer's disease studies on ClinicalTrials.gov name it in an outcome measure, 28 of them in a primary outcome: 4% of the condition's 1,673 studies with a cognitive outcome, against 2% of all of them. It is the 12th most named test in dementia and Alzheimer's trials.
Which tests do dementia and Alzheimer's trials use with the Clock Drawing Task?
The Trail Making Test (33 studies), Verbal Fluency (26 studies) and the Picture Naming Test (22 studies).
When do dementia and Alzheimer's trials measure the Clock Drawing Task?
Half of the primary outcomes that name the Clock Drawing Task are measured within 5 months of the start, and the middle half from 9 weeks to 11 months. 26 primary outcomes give a duration.
How many completed dementia and Alzheimer's trials that use the Clock Drawing Task have reported results?
22 of the 34 completed studies that name it, 65%, have reported results: 10 posted them on ClinicalTrials.gov, 15 have a results paper linked to the registry record, and 3 did both. The other 12 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Clock Drawing Task in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.